These findings indicate that expression status of ZIP10 is a major determinant for anti-tumor activity of mannose in thyroid cancer cells, and may be a potential therapeutic target to sensitize the response of cancer cells to mannose. Here, SLC39A10 is linked to thyroid cancer.